gold has been researched along with valproic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hackett, T; Kelton, JG; Powers, P | 1 |
| Abd-Elhakim, YM; Al-Ayadhi, LY; Selim, ME | 1 |
| Belmonte-Reche, E; Corpas-López, V; de Pedro, N; Díaz-Gavilán, M; Franco-Montalbán, F; Gómez-Vidal, JA; López-Viota, J; López-Viota, M; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F; Pérez-Del Palacio, J | 1 |
1 review(s) available for gold and valproic acid
| Article | Year |
|---|---|
Drug-induced platelet destruction.
Topics: Binding Sites, Antibody; Blood Platelets; Cell Differentiation; Cell Migration Inhibition; Clot Retraction; Complement Fixation Tests; Gold; Heparin; Humans; Immunoglobulin G; Intradermal Tests; Platelet Aggregation; Platelet Factor 3; Prednisone; Quinidine; Ristocetin; Serotonin; Thrombocytopenia; Thromboembolism; Urea; Valproic Acid | 1982 |
2 other study(ies) available for gold and valproic acid
| Article | Year |
|---|---|
Pancreatic response to gold nanoparticles includes decrease of oxidative stress and inflammation in autistic diabetic model.
Topics: Animals; Antioxidants; Autistic Disorder; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Gene Expression Regulation; Gold; Lipid Peroxidation; Male; Metal Nanoparticles; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Valproic Acid | 2015 |
A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis.
Topics: Administration, Oral; Anilides; Animals; Antiprotozoal Agents; Drug Delivery Systems; Female; Gold; Histone Deacetylase Inhibitors; Hydroxamic Acids; Leishmania infantum; Leishmaniasis, Visceral; Mice, Inbred BALB C; Mice, Inbred ICR; Nanoparticles; Valproic Acid; Vorinostat | 2019 |